Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. 4 Grant or award EVP, Gen. Counsel, Corp. Sec. acquired 20,000 shares (grant or award)
  2. 4 Grant or award CFO acquired 20,000 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 58,000 shares (grant or award)
  4. 4 Grant or award Chief Commercial Officer acquired 12,000 shares (grant or award)
  5. 4 Grant or award Director acquired 2,500 shares (grant or award)
  6. 4 Grant or award Director acquired 2,500 shares (grant or award)
  7. 4 Grant or award Director acquired 2,500 shares (grant or award)
  8. 4 Grant or award Director acquired 2,500 shares (grant or award)
  9. 4 Grant or award Director acquired 2,500 shares (grant or award)
  10. 4 Open-market sale President and CEO sold 6,494 shares at $2.61 ($16,938)
  11. 4 Open-market sale Senior VP, Finance & CAO sold 1,159 shares at $2.59 ($3,002)
  12. 4 Open-market sale EVP, Gen. Counsel, Corp. Sec. sold 2,153 shares at $2.59 ($5,576)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award EVP, Gen. Counsel, Corp. Sec. acquired 13,000 shares (grant or award)
  18. 4 Grant or award Director acquired 1,900 shares (grant or award)
  19. 4 Grant or award Director acquired 1,900 shares (grant or award)
  20. 4 Grant or award Director acquired 1,900 shares (grant or award)

Page 3 of 22 · 436 filings